Filtros : "Indexado no na Base de dados Biological Abstracts" "Muscará, Marcelo Nicolás" Limpar

Filtros



Limitar por data


  • Fonte: European Journal of Pharmacology. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAMARA, Paula R. S. et al. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats. European Journal of Pharmacology, v. 589, n. 1-3, p. 245-250, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.05.004. Acesso em: 08 nov. 2024.
    • APA

      Camara, P. R. S., Ferraz, G. J. N., Franco-Penteado, C. F., Sbragia-Neto, L., Meirelles, L. R., Teixeira, S. A., et al. (2008). Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats. European Journal of Pharmacology, 589( 1-3), 245-250. doi:10.1016/j.ejphar.2008.05.004
    • NLM

      Camara PRS, Ferraz GJN, Franco-Penteado CF, Sbragia-Neto L, Meirelles LR, Teixeira SA, Muscará MN, Velloso LA, Antunes E, Ferraz JGP. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats [Internet]. European Journal of Pharmacology. 2008 ; 589( 1-3): 245-250.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejphar.2008.05.004
    • Vancouver

      Camara PRS, Ferraz GJN, Franco-Penteado CF, Sbragia-Neto L, Meirelles LR, Teixeira SA, Muscará MN, Velloso LA, Antunes E, Ferraz JGP. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats [Internet]. European Journal of Pharmacology. 2008 ; 589( 1-3): 245-250.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.ejphar.2008.05.004
  • Fonte: Biochemical and Biophysical Research Communications. Unidades: ICB, FM, FCF

    Assuntos: FISIOLOGIA, FARMACOLOGIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HEBEDA, Cristina B. et al. In vivo blockade of Ca+2-dependent nitric oxide synthases impairs expressions of L-selectin and PECAM-1. Biochemical and Biophysical Research Communications, v. 377, n. 2, p. 694-698, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.bbrc.2008.10.055. Acesso em: 08 nov. 2024.
    • APA

      Hebeda, C. B., Teixeira, S. A., Muscará, M. N., Vinolo, M. A. R., Curi, R., Mello, S. B. V. de, & Farsky, S. H. P. (2008). In vivo blockade of Ca+2-dependent nitric oxide synthases impairs expressions of L-selectin and PECAM-1. Biochemical and Biophysical Research Communications, 377( 2), 694-698. doi:10.1016/j.bbrc.2008.10.055
    • NLM

      Hebeda CB, Teixeira SA, Muscará MN, Vinolo MAR, Curi R, Mello SBV de, Farsky SHP. In vivo blockade of Ca+2-dependent nitric oxide synthases impairs expressions of L-selectin and PECAM-1 [Internet]. Biochemical and Biophysical Research Communications. 2008 ; 377( 2): 694-698.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.bbrc.2008.10.055
    • Vancouver

      Hebeda CB, Teixeira SA, Muscará MN, Vinolo MAR, Curi R, Mello SBV de, Farsky SHP. In vivo blockade of Ca+2-dependent nitric oxide synthases impairs expressions of L-selectin and PECAM-1 [Internet]. Biochemical and Biophysical Research Communications. 2008 ; 377( 2): 694-698.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1016/j.bbrc.2008.10.055
  • Fonte: British Journal of Pharmacology. Unidade: ICB

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HERRERA, B. S. et al. An endogenous regulator of inflammation, resolving E1, modulates osteoclast differentiation and bone resorption. British Journal of Pharmacology, v. 155, n. 8, p. 1214-1223, 2008Tradução . . Disponível em: https://doi.org/10.1038/bjp.2008.367. Acesso em: 08 nov. 2024.
    • APA

      Herrera, B. S., Ohira, T., Gao, L., Omori, K., Yang, R., Zhu, M., et al. (2008). An endogenous regulator of inflammation, resolving E1, modulates osteoclast differentiation and bone resorption. British Journal of Pharmacology, 155( 8), 1214-1223. doi:10.1038/bjp.2008.367
    • NLM

      Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M, Muscará MN, Serhan CN, Van Dyke TE, Gyurko R. An endogenous regulator of inflammation, resolving E1, modulates osteoclast differentiation and bone resorption [Internet]. British Journal of Pharmacology. 2008 ; 155( 8): 1214-1223.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1038/bjp.2008.367
    • Vancouver

      Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M, Muscará MN, Serhan CN, Van Dyke TE, Gyurko R. An endogenous regulator of inflammation, resolving E1, modulates osteoclast differentiation and bone resorption [Internet]. British Journal of Pharmacology. 2008 ; 155( 8): 1214-1223.[citado 2024 nov. 08 ] Available from: https://doi.org/10.1038/bjp.2008.367

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024